Status | Study |
Recruiting |
Study Name: Open-Label Study to Evaluate Efficacy and Safety of SCY-078 in Patients With Refractory or Intolerant Fungal Diseases Condition: Invasive Candidiases Mucocutaneous Candidiasis Date: 2017-02-14 Interventions: Drug: SCY-078 Experimental Study Drug |
Recruiting |
Study Name: Nitric Oxide Releasing Solution (NORS) Footbath to Treat Athlete's Foot Condition: Tinea Pedis Date: 2016-08-04 Interventions: Drug: Nitric Oxide Delivered a |
Completed |
Study Name: Interest of ß 1-3 D Glucan Assays in Screening for the Onset of Invasive Aspergillosis in Neutropenic Patients With Acute Leukaemia. Condition: Invasive Fungal Infections Date: 2016-07-28 Interventions: Biological: blood samples |
Completed |
Study Name: Safety and Efficacy of Product 33525 in Pediatric Subjects With Tinea Corporis Condition: Tinea Corporis Date: 2016-05-06 Interventions: Drug: Luliconazole Cream 1% Cr |
Terminated |
Study Name: Post Marketing Study to Evaluate the Safety and Efficacy of Micafungin Against Fungal Infections Caused by Candida Spp or Aspergillus Spp Condition: Candidiasis Aspergillosis Date: 2015-12-16 Interventions: Drug: Micafungin Injection |
Recruiting |
Study Name: CAMB/MAT2203 in Patients With Mucocutaneous Candidiasis Condition: Candidiasis, Chronic Mucocutaneous Date: 2015-11-16 Interventions: Drug: Amphotericin B Lipid crystal nano-particle formulation of amphotericin B |
Not yet recruiting |
Study Name: Effectiveness Study of Ketoconazole and Betamethasone to Treat Fungal Infection and Dermatophytosis Condition: Tinea Date: 2015-10-20 Interventions: Drug: Ketoconazole + betamethasone dipropionate |
Completed |
Study Name: A Clinical Study to Evaluate the Pharmacokinetics of Lozanoc and Sporanox in Korean Healthy Male Volunteers Condition: Superficial Mycoses Dermatomycoses Date: 2015-07-07 Interventions: Drug: Lozanoc 50mg Lozanoc 50m |
Completed |
Study Name: An Open Label Pharmacokinetic Study of Naftin for Tinea Corporis Condition: Tinea Corporis Date: 2014-10-29 Interventions: Drug: Naftin® Cream, 2% (younger pediatric cohort) |
Completed |
Study Name: Pediatric Subjects With Tinea Corporis Condition: Tinea Corporis Date: 2014-08-25 Interventions: Drug: Naftin Cream Drug: Placebo Cream |